Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-21-001726
Filing Date
2021-12-10
Accepted
2021-12-10 16:01:29
Documents
1
Period of Report
2021-12-08

Document Format Files

Seq Description Document Type Size
1 e621144_4-chivukula.html 4  
1 e621144_4-chivukula.xml 4 3371
  Complete submission text file 0001193805-21-001726.txt   4757
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address
Chivukula Pad (Reporting) CIK: 0001727317 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38942 | Film No.: 211485227

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Issuer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations